| Literature DB >> 35087809 |
Jiang-Nan Fu1,2, Xing Wang3,4, Meng Yang1,2, You-Rong Chen1,2, Ji-Ying Zhang1,2, Rong-Hui Deng1,2, Zi-Ning Zhang1,2, Jia-Kuo Yu1,2, Fu-Zhen Yuan1,2.
Abstract
Over centuries, several advances have been made in osteochondral (OC) tissue engineering to regenerate more biomimetic tissue. As an essential component of tissue engineering, scaffolds provide structural and functional support for cell growth and differentiation. Numerous scaffold types, such as porous, hydrogel, fibrous, microsphere, metal, composite and decellularized matrix, have been reported and evaluated for OC tissue regeneration in vitro and in vivo, with respective advantages and disadvantages. Unfortunately, due to the inherent complexity of organizational structure and the objective limitations of manufacturing technologies and biomaterials, we have not yet achieved stable and satisfactory effects of OC defects repair. In this review, we summarize the complicated gradients of natural OC tissue and then discuss various osteochondral tissue engineering strategies, focusing on scaffold design with abundant cell resources, material types, fabrication techniques and functional properties.Entities:
Keywords: biomaterials; fabrication; osteochondral repair; scaffolds; tissue engineering
Year: 2022 PMID: 35087809 PMCID: PMC8787149 DOI: 10.3389/fbioe.2021.812383
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
FIGURE 1The components of native osteochondral (OC) tissue.
FIGURE 2Different gradients in the osteochondral (OC) tissue with regard to biochemistry, mechanics, architecture, electrics and metabolism.
Cell resources in osteochondral tissue engineering.
| Cell types | Cell sources | Relevant characteristics |
|---|---|---|
| Tissue-specific cells | Chondrocytes | More functional cartilaginous tissue formation |
| Limited quantity in the native tissue | ||
| High integration into the surrounding matrix | ||
| Dedifferentiation capacity during culture and expansion | ||
| Osteoblasts | The expression of Runx2 peaks in immature osteoblasts and reduces at maturity | |
| Enhanced apoptosis by p53 and accelerated differentiation through Akt-FoxOs pathway | ||
| Osteoblast-derived VEGF promotes bone repair and homeostasis | ||
| Progenitor cells | BM-MSCs | Most widely used, but highly invasive |
| The frequency, proliferation efficiency and differentiation potential decline with age | ||
| Immunomodulatory functions, facilitating better tissue survival | ||
| UC-MSCs | Inexhaustible supply, noninvasive procurement and high purity | |
| Faster proliferation rates, greater expansion capability and broad multipotency | ||
| More primitive—expressing both MSC and ESC markers | ||
| No or only mild immune response based on recent evidence | ||
| AT-MSCs | Increased osteogenic differentiation by allylamine modification | |
| The deposition of chemical groups (e.g., NH2 and COOH) affects chondrogenic and osteogenic lineages | ||
| SDSCs | Better proliferation and chondrogenic differentiation performance than BM-MSCs and AT-MSCs | |
| Weaker osteogenic capability than BM-MSCs | ||
| Elevated ECM deposition and inhibited hypertrophy of chondrocytes | ||
| AFSCs | Expressing Runx2, osterix, osteopontin et al. and producing extracellular calcium stores during differentiation | |
| Typical differentiation process into cells of mesodermal origin regulated by growth factors (e.g., TGF-β, IGF-1 and EGF) | ||
| USCs | A recently reported candidate for seed cells in tissue engineering | |
| Osteogenic and chondrogenic potentials worth exploring | ||
| Simple isolation and culture, non-invasive and easy obtainment, low-cost and high efficiency |
Abbreviations: BM-MSCs, Bone marrow-derived MSCs; UC-MSCs, Umbilical cord MSCs; AT-MSCs, Adipose tissue-derived MSCs; SDSCs, Synovium-derived MSCs; AFSCs, Amniotic fluid-derived stem cells; USCs, Urine-derived stem cells.
FIGURE 3Comparison of stem cells from different sources commonly used in scaffold-based osteochondral (OC) tissue engineering strategies. Biological characteristics are shown as different color blocks from high to low, inspired by Zha et al. (2021). * USCs are reported to promote the chondrogenesis of BM-MSCs by paracrine action in the co-culture system (Gao et al., 2016).
Fabrication techniques of scaffolds in osteochondral tissue engineering.
| Techniques | Processes | The pros and cons |
|---|---|---|
| Lyophilization | The mixture is cooled by freeze-drying to eliminate the solvent and water, forming macropores and micropores in the scaffold structure | • The pore size and porosity can be modified by solution characteristics (e.g., concentration and viscosity), quenching rate and freezing temperature (Tf). |
| • The use of organic solvents; instability of the emulsion | ||
| Freeze casting | The manufacturing technique includes the controlled solidification process, the sublimation of solvents under reduced pressure and subsequent densification | • The applicability to various materials; changeable micro- and macrostructures of obtained scaffolds |
| Gas foaming | The raw materials are kept under a high carbon dioxide pressure to produce porous structures | • The uniformity of cell infiltration should be improved. |
| Microfluidic foaming | The foam is generated via microfluidics under highly controlled and reproducible conditions | • Homogeneous pore monodispersity and interconnection; abundant cell infiltration; versatility. |
| • There is still room to expand the range of applicable biomaterials | ||
| Sol-gel process | The sol-gel method can result in oxides or hybrid materials in soft conditions | • Combined with other techniques, such as 3D printing, this approach can open a new way for the design of biocompatible hydrogels by promoting cross-linking. |
| Solvent casting | The polymer solution is first combined with necessary particles and then poured onto pre-designed molds | • Addition of functional elements such as drugs and growth factors |
| • The potential toxicity of organic solvents | ||
| Melt molding | The mixture of powdered polymers and porogen is loaded into pre-designed molds and annealed at an elevated pressure | • Porous scaffolds with desired morphological features |
| • The difficulty of later particulate leaching; high processing temperature; inapplicability of organic solvents | ||
| Compression molding | The mixture is pressed into molds under heat and pressure to obtain the required structures. | • High-pressure molding can compact the stacking structure and optimize mechanical performance |
| Particulate leaching | The preliminarily obtained scaffolds are treated and soaked to leach out particles | • Porous structures adjusted by the added porogen as required |
| • The technical demands for better control of pore morphology and interconnection; extra time consumption | ||
| Phase separation process | The polymer solution is quenched under the freezing point (Tk) and separated into a polymer-rich phase and a polymer-poor phase which will solidify and crystallize respectively. Crystals are removed subsequently | • The scaffold structure can be tunable on account of processing parameters such as quenching temperature and rate |
| • The improvement and integration of techniques is needed to optimize the probably unfavorable pore structure | ||
| Electrospinning | Under a strong electric field, a polymer solution, emulsion or melt is extruded through a spinneret to produce fibre and deposit on an appropriate collector | • Structures resembling the native ECM; encapsulation of bioactive elements |
| • Poor control over architectures restricted by environmental parameters; difficulty in producing 3D structures; limited cell passage and substance exchange related to pore size; environmental safety issues | ||
| Additive manufacturing (AM) | The electrohydrodynamic technique, also known as rapid prototyping or solid freeform fabrication, is classified into seven processes: vat photopolymerization, material jetting, material extrusion, powder bed fusion, directed energy deposition, sheet lamination and binder jetting. | • Better control over architectures; flexibility to scale-up customisation; standardisation and repeatability of manufacturing |
| • Narrow range of suitable materials, time-consuming layer-by-layer processing and high costs |
FIGURE 4Electrospun fibers, obtained by basic electrospinning setup (A), can be modified by physical or chemical techniques. Post-fabrication surface modifications of electrospun fibers (B) were adapted with permission from ref (Gonçalves et al., 2021). Copyright 2021 by MDPI Inc.
FIGURE 5Porous and hydrogel scaffolds. Bilayered PLGA porous scaffolds (A) with different pore sizes shown in scanning electron microscopy (SEM) images (B: a-e). The boundaries between the layers were magnified (B: f-j). Bilayered porous scaffold consisting of non-woven PGA meshes (C) and PLGA/PEG foams (D). PCL porous scaffold with a 0/60/120° lay-down pattern (E). Muti-layered scaffolds with porous 3D printing PLGA/TCP bone layer (F) were shown in digital pictures (F: a), SEM images (F: b-c) and micro-CT reconstructive images (F: d), respectively. Bilayered CAN-PAC hydrogel (G: a) and the SEM images of upper (G: b) and lower layers (G: c). SEM images of the upper and lower layers of chitosan hydrogel scaffold (H). Tri-phasic scaffolds made of gelMA hydrogel and PCL/HA (I: a). CD31 immunohistochemical analysis showed the presence of HUVECs in the PCL-PCL/HA phase (I: b). (A, B) Adapted with permission from ref (Duan et al., 2014). Copyright 2013 by WILEY PERIODICALS Inc. (C, D) Adapted with permission from ref (Schaefer et al., 2000). Copyright 2000 by Elsevier Science Ltd. (E) Adapted with permission from ref (Cao et al., 2003). Copyright 2003 by Mary Ann Liebert Inc. (F) Adapted with permission from ref (Jia et al., 2018). Copyright 2018 by American Chemical Society. (G) Adapted with permission from ref (Liao et al., 2017). Copyright 2017 by Nature Publishing Group. (H) Adapted with permission from ref (Dehghani Nazhvani et al., 2021). Copyright 2021 by Elsevier Inc. (I) Adapted with permission from ref (Pirosa et al., 2021). Copyright 2021 by Elsevier Ltd.
FIGURE 6Microsphere (MS) scaffolds can be classified into MS-leached scaffolds (A) and MS-incorporated scaffolds (B). Chondrocyte-encapsulated MSs can provide protection and achieve targeted carriage (B: a). MS scaffolds loaded with vancomycin hydrochloride (VH) can reduce inflammation after implantation (B: b). MS scaffolds loaded with OIC-A006 (B: c). Multi-layered scaffold consisting of pre-integrated hydrogel (G), hydrogel + microsphere interface (I) and microsphere (M) bone layers (B: d). (B-a) Adapted with permission from ref (Bozkurt et al., 2019). Copyright 2019 by BioMed Central Ltd. (B-b) Adapted with permission from ref (He et al., 2021). Copyright 2020 by Elsevier Ltd. (B-c) Adapted with permission from ref (Lin et al., 2016). Copyright 2016 by Taylor and Francis Group. (B-d) Adapted with permission from ref (Jiang et al., 2010). Copyright 2010 by Biomedical Engineering Society.
FIGURE 7Composite scaffolds. The fabrication process (A) and SEM images (B) of a bilayered composite scaffold consisting of 4% CHA cartilage layer (B: a) and 6% CA + 0.5%HAp bone layer (B: c) with an integrated interface (B: b). A bilayered CS/CS-β-TCP scaffold (C) was prepared and observed by gross appearance (C: a–c) and SEM (C: d–f). A composite scaffold with four functional layers improved the integration of implants with host tissues (D). (A and B) Adapted with permission from ref (Erickson et al., 2019). Copyright 2019 by Springer Science + Business Media LLC. (C) Adapted with permission from ref (Xu et al., 2021). Copyright 2021 by Mary Ann Liebert Inc. (D) Adapted with permission from ref (Chen et al., 2018). Copyright 2018 by Elsevier B.V.
Hierarchical commercial products for OC tissue regeneration approved in the European Union.
| Product name | Company | Classification | Materials | Figures |
|---|---|---|---|---|
| TruFit™ | Smith and Nephew | Biphasic | PLGA-PGA (75:25), calcium sulfate |
|
| MaioRegen™ | Finceramica | Triphasic | Type I collagen, magnesium-enriched hydroxyapatite |
|
| ChondroMimetic® | TiGenix | Biphasic | Type II collagen, type I collagen, chondroitin sulfate, calcium phosphate | — |
| Agili-C™ | CartiHeal Ltd | Biphasic | Hyaluronic acid, crystalline aragonite |
|
| BioMatrix CRD | Kensey Nash | Biphasic | Bovine collagen, β-TCP, PLA | — |
Abbreviations: PLGA, poly(lactic-co-glycolic) acid; PGA, polyglycolic acid; PLA, polylactic acid. Figures were reprinted from ref (Zhang B et al., 2020) with permission from The Royal Society of Chemistry, Copyright 2020.
FIGURE 8(A) 3D-printed Sr5(PO4)2SiO4 (SPS) bioactive ceramic scaffolds can promote osteochondral defect reconstruction possibly by releasing Sr and Si ions (a-d). (B) A polydopamine−chondroitin sulfate−polyacrylamide (PDA−CS−PAM) hydrogel with tissue adhesiveness and super mechanical properties for cartilage regeneration. (A) Adapted with permission from ref (Deng et al., 2018). Copyright 2018 by Ivyspring International Publisher. (B) Adapted with permission from ref (Han et al., 2018). Copyright 2018 by American Chemical Society.